应该给女性使用脱氢表雄酮吗?
本文综述1985至2021年文献,评估雄激素前体脱氢表雄酮(DHEA)在女性中的获益与风险。数据显示DHEA对原发性或继发性肾上腺功能不全或厌食症女性的生活质量和情绪有小幅获益,但对正常女性的更年期症状、性功能、认知或整体健康无一致益处;局部给药对外阴阴道萎缩有益;不推荐用于改善卵巢储备功能减退女性的排卵诱导;长期使用有雄激素和雌激素副作用风险。
要点
- DHEA对原发性或继发性肾上腺功能不全或厌食症女性的生活质量和情绪有小幅获益,但对焦虑或性功能无益。
- 正常女性使用DHEA对更年期症状、性功能、认知或整体健康无一致益处。
- 局部DHEA对外阴阴道萎缩有益;不推荐用于改善卵巢储备功能减退女性的排卵诱导反应。
核心结论
- 数据支持DHEA对原发性或继发性肾上腺功能不全或厌食症女性的生活质量和情绪有小幅获益,但对焦虑或性功能无益。
- 正常女性使用DHEA对更年期症状、性功能、认知或整体健康未观察到一致有益效应。
- 局部给予DHEA对外阴阴道萎缩显示有益。
- 不推荐使用DHEA改善卵巢储备功能减退女性的排卵诱导反应。
- 高生理或药理剂量DHEA的风险包括雄激素和雌激素副作用,长期给药令人担忧。
研究设计与样本
- 综述1985至2021年文献,评估雄激素前体在女性中的潜在获益与风险。
主要发现
- DHEA在青春期早期升高,第二和第三个十年达峰,此后下降,独立于绝经状态。
- 研究评估了DHEA治疗在抗衰老、性功能障碍、不孕、代谢骨骼健康、认知和健康感方面的潜在获益,对象包括原发性肾上腺功能不全、垂体功能减退和厌食症等激素缺乏状态以及正常女性。
- 数据支持DHEA对原发性或继发性肾上腺功能不全或厌食症女性的生活质量和情绪有小幅获益,但对焦虑或性功能无益。
- 正常女性使用DHEA对更年期症状、性功能、认知或整体健康未观察到一致有益效应。
- 局部给予DHEA对外阴阴道萎缩显示有益。
关键数值与推荐
- 不推荐使用DHEA改善卵巢储备功能减退女性的排卵诱导反应。
- 高生理或药理剂量DHEA的风险包括雄激素和雌激素副作用,长期给药令人担忧。
临床怎么用
- 对于49岁艾迪生病女性,使用低剂量雌激素加周期性黄体酮治疗更年期症状,稳定接受氢化可的松10 mg晨服和5 mg午后早期服及氟氢可的松0.05 mg每晨服,询问是否加用DHEA及剂量。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Androgen prohormones such as dehydroepiandrosterone (DHEA) increase in early puberty, peak in the second and third decade, and thereafter decline, independent of menopausal status. Investigators have examined their potential beneficial effects in normal women and those with DHEA-deficient states. EVIDENCE ACQUISITION: A review of the literature from 1985 to 2021 on the potential benefits and risks of androgen prohormones in women. EVIDENCE SYNTHESIS: Studies have examined the potential benefit of DHEA therapy for anti-aging, sexual dysfunction, infertility, metabolic bone health, cognition, and wellbeing in hormone-deficient states such as primary adrenal insufficiency, hypopituitarism, and anorexia as well as administration to normal women across the lifespan. CONCLUSIONS: Data support small benefits in quality of life and mood but not for anxiety or sexual function in women with primary or secondary adrenal insufficiency or anorexia. No consistent beneficial effects of DHEA administration have been observed for menopausal symptoms, sexual function, cognition, or overall wellbeing in normal women. Local administration of DHEA shows benefit in vulvovaginal atrophy. Use of DHEA to improve induction of ovulation response in women with diminished ovarian reserve is not recommended. Risks of high physiologic or pharmacologic use of DHEA include androgenic and estrogenic side effects which are of concern for long-term administration. CLINICAL CASE: A 49-year-old woman with Addison's disease who is on low dose estrogen with cyclic progesterone therapy for menopausal symptoms returns for follow-up. She is on a stable glucocorticoid replacement strategy of hydrocortisone 10 mg in the morning and 5 mg in the early afternoon and fludrocortisone 0.05 mg each morning. She has read on the internet that additional therapy with DHEA may help her overall quality of life and libido. She asks whether she should add this therapy to her regimen and at what dose.
引用
- Wierman ME, Kiseljak-Vassiliades K. Should Dehydroepiandrosterone Be Administered to Women? J Clin Endocrinol Metab. 2022. PMID: 35254428. doi:10.1210/clinem/dgac130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。